Erratum: Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

被引：0
|
作者：
S K Kumar
J H Lee
J J Lahuerta
G Morgan
P G Richardson
J Crowley
J Haessler
J Feather
A Hoering
P Moreau
X LeLeu
C Hulin
S K Klein
P Sonneveld
D Siegel
J Bladeé
H Goldschmidt
S Jagannath
J S Miguel
R Orlowski
A Palumbo
O Sezer
S V Rajkumar
机构：
来源：
Leukemia | 2012年 / 26卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Correction to: Leukemia (2012) 26, 149–157; doi:10.1038/leu.2011.196 Since the publication of this paper, the authors have noticed that one of the author names in the appendix was incorrectly listed as Hareth Nari. It should be listed as follows: Hareth Nahi, Karolinska University Hospital, Stockholm, Sweden.
引用
收藏
页码：1153 / 1153
相关论文
共 50 条
  • [1] Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
    Kumar, S. K.
    Lee, J. H.
    Lahuerta, J. J.
    Morgan, G.
    Richardson, P. G.
    Crowley, J.
    Haessler, J.
    Feather, J.
    Hoering, A.
    Moreau, P.
    LeLeu, X.
    Hulin, C.
    Klein, S. K.
    Sonneveld, P.
    Siegel, D.
    Blade, J.
    Goldschmidt, H.
    Jagannath, S.
    Miguel, J. S.
    Orlowski, R.
    Palumbo, A.
    Sezer, O.
    Rajkumar, S. V.
    Durie, B. G. M.
    LEUKEMIA, 2012, 26 (01) : 149 - 157
  • [2] Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
    S K Kumar
    J H Lee
    J J Lahuerta
    G Morgan
    P G Richardson
    J Crowley
    J Haessler
    J Feather
    A Hoering
    P Moreau
    X LeLeu
    C Hulin
    S K Klein
    P Sonneveld
    D Siegel
    J Bladé
    H Goldschmidt
    S Jagannath
    J S Miguel
    R Orlowski
    A Palumbo
    O Sezer
    S V Rajkumar
    B G M Durie
    Leukemia, 2012, 26 : 149 - 157
  • [3] Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study (vol 26, pg 149, 2012)
    Kumar, S. K.
    Lee, J. H.
    Lahuerta, J. J.
    Morgan, G.
    Richardson, P. G.
    Crowley, J.
    Haessler, J.
    Feather, J.
    Hoering, A.
    Moreau, P.
    Leleu, X.
    Hulin, C.
    Klein, S. K.
    Sonneveld, P.
    Siegel, D.
    Blade, J.
    Goldschmidt, H.
    Jagannath, S.
    Miguel, J. S.
    Orlowski, R.
    Palumbo, A.
    Sezer, O.
    Rajkumar, S. V.
    Durie, B. G. M.
    Nahi, Hareth
    LEUKEMIA, 2012, 26 (05) : 1153 - 1153
  • [4] Natural History of Multiple Myeloma Relapsing After Therapy with IMiDs and Bortezomib: A Multicenter International Myeloma Working Group Study.
    Kumar, Shaji
    Blade, Joan
    Crowley, John
    Goldschmidt, Harmut
    Hoering, Antje
    Jagannath, Sundar
    Jose Lahuerta, Juan
    Laubach, Jacob
    Moreau, Philippe
    Morgan, Gareth
    Orlowski, Robert Z.
    Palumbo, Antonio
    Richardson, Paul
    San Miguel, Jesus F.
    Sezer, Orhan
    Siegel, David
    Sonneveld, Pieter
    Szymonifka, Jackie
    Vincent Rajkumar, S.
    Durie, Brian G. M.
    BLOOD, 2009, 114 (22) : 1123 - 1124
  • [5] OUTCOME OF PATIENTS WITH MYELOMA RELAPSING AFTER IMID AND BORTEZOMIB THERAPY: A MULTICENTER STUDY FROM THE INTERNATIONAL MYELOMA FOUNDATION WORKING GROUP
    Kumar, K.
    Blade, J.
    Crowley, J.
    Goldschmidt, H.
    Hoering, A.
    Jagannath, S.
    Klein, S.
    Lahuerta, J.
    Laubach, J.
    Lee, J.
    Moreau, P.
    Morgan, G.
    Orlowski, R.
    Palumbo, A.
    Richardson, P.
    San Miguel, J.
    Sezer, O.
    Siegel, D.
    Sonneveld, P.
    Szymonifka, J.
    Rajkumar, V.
    Durie, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 151 - 152
  • [6] Treatment patterns and outcome among patients with multiple myeloma relapsing and or refractory to bortezomib and immunomodulatory drugs: A multicenter International Myeloma Working Group study
    Kumar, S.
    Crowley, J.
    Klein, S. K.
    Lahuerta, J. J.
    Lee, J.
    Moreau, P.
    Morgan, G.
    Richardson, P. G.
    Siegel, D. S.
    Durie, B. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] What is the survival of patients with relapsed multiple myeloma after IMiDs and bortezomib?
    Macro, Margaret
    HEMATOLOGIE, 2012, 18 (02): : 92 - 93
  • [8] Prognosis of relapsed multiple myeloma after treatment by IMiDs and Bortezomib
    Fouquet, Guillemette
    Leleu, Xavier
    HEMATOLOGIE, 2011, 17 (05): : 310 - 310
  • [9] Outcomes after Initial Relapse of Multiple Myeloma: An International Myeloma Working Group Study
    Kumar, Shaji K.
    Lee, Jae Hoon
    Dimopoulos, Meletios A.
    Terpos, Evangelos
    Kastritis, Efstathios
    Chng, Wee Jou
    Jurczyszyn, Artur J.
    Handa, Hiroshi
    Ozaki, Shuji
    Leleu, Xavier
    Moreau, Philippe
    Jose Lahuerta, Juan
    Shustik, Chaim
    Waller, Daniel Dirck
    Beksac, Meral
    Vij, Ravi
    Kim, Kihyun
    Kim, Jin Seok
    Badros, Ashraf Z.
    Alsina, Melissa
    Durie, Brian G. M.
    BLOOD, 2015, 126 (23)
  • [10] Outcomes of Patients with t(11;14) Multiple Myeloma: An International Myeloma Working Group Multicenter Study
    Kumar, Shaji K.
    Lu, Jin
    Liu, Yang Terry
    Bittrich, Max
    Du, Juan
    Goldschmidt, Hartmut
    Kyriakou, Charalampia
    Reece, Donna E.
    Kim, Kihyun
    Mateos, Maria-Victoria
    De La Calle, Veronica Gonzalez
    Chen, Wenming
    Ludwig, Heinz
    Merlini, Giampaolo
    Mangiacavalli, Silvia
    Dimopoulos, Meletios A.
    Kastritis, Eftathios
    Min, Chang-Ki
    Esteves, Graca
    Yee, Andrew J.
    Raje, Noopur S.
    Rosta, Emily
    Haltner, Anja
    Cameron, Chris
    Durie, Brian G. M.
    BLOOD, 2019, 134
12345